This is just what I know offhand, and it would have to be triple checked, BUT... from what I recall seeing, we’re looking at solely solid tumors for now. I think Leronlimab will have a significant impact on MM specifically one day, as an adjunct to support bone marrow transplants / avoid GVH and rejection.